USPTO serial 90980842
ADC THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 23, 2024
- Examiner
- EULIN, INGRID C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ADC THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
TRACY-GENE G. DURKIN
TRACY-GENE G. DURKIN Sterne, Kessler, Goldstein & Fox P.L.L.C.1101 K Street, NW10th FloorWASHINGTON, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for use in the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, pharmaceutical antibodies; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for the treatment of oncological diseases, disorders, and conditions; biological preparations for the treatment of oncological diseases, and conditions | ACTIVE | May 3, 2021 |
| 042 | Pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals | ACTIVE | — |
| 044 | Providing medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, and health | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ADC Therapeutics SA
- Other trademarks owned by ADC Therapeutics SA
- Other trademarks owned by ADC Therapeutics SA
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ADC THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 25, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 23, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 23, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 20, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 19, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 27, 2024 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 26, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 26, 2024 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 5, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 18, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jan 18, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jan 18, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jan 18, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 15, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 13, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 13, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 13, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 20, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 18, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 18, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 18, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 19, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 24, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 24, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 4, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 20, 2022 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Apr 20, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 13, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 13, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 12, 2022 | ALIE | ASSIGNED TO LIE | — |
| Apr 7, 2022 | ALIE | ASSIGNED TO LIE | — |
| Apr 6, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 6, 2022 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Apr 6, 2022 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 6, 2022 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Oct 6, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 6, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 6, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 6, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 6, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 9, 2020 | NWAP | NEW APPLICATION ENTERED | — |